作为复发性呼吸道乳头瘤病的关键因素的VEGF:叙述性审查
Sandra Gazzini1, Raffaele Cerullo2, Davide Soloperto3
1Division of Otolaryngology, Head and Neck Surgery Department, University Hospital of Verona, 37134 Verona, Italy.
Current issues in molecular biology
|July 26, 2024
概括
复发性呼吸道乳头炎 (RRP) 是一种良性HPV相关疾病. 血管内皮生长因子 (VEGF) 在RRP中起着关键作用,导致像贝瓦西祖马布这样的抗血管性治疗具有积极的结果.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 病理生理学 病理生理学
背景情况:
- 复发性呼吸道乳头炎 (RRP) 是一种由人类乳头瘤病毒 (HPV) 6型和11型引起的良性疾病.
- RRP可能导致频繁复发,严重影响患者的生活质量,特别是在儿童中.
- 虽然HPV在恶性瘤中的作用得到了充分的研究,但RRP的分子格局,包括血管生成,尚未得到充分的探索.
研究的目的:
- 审查血管内皮生长因子 (VEGF) 在RRP病理生理学中的作用.
- 要总结RRP中VEGF信号激活的分子通路.
- 讨论RRP管理中的抗血管性疗法的当前和未来应用.
主要方法:
- 关于VEGF,血管生成和RRP的研究的文献综述.
- 对VEGF在RRP中的作用背后的分子机制的分析.
- 对RRP的抗血管性治疗的临床数据的评估.
主要成果:
- 在RRP中,VEGF是血管生成过程的核心.
- VEGF信号通路与RRP的发展和进展有关.
- 作为VEGF抑制剂的贝瓦齐祖马布 (bevacizumab) 作为RRP的辅助疗法显示出有前途的结果.
结论:
- 在RRP病变发生过程中,VEGF是关键因素.
- 准VEGF途径为RRP提供了一个可行的治疗策略.
- 抗血管生成疗法在管理RRP方面取得了重大进展.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


